(Q28216743)

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Endocrine pharmacology of antiestrogens as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Determinants of promoter-specific activity by glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Antiglucocorticoid steroids have increased agonist activity in those hepatoma cell lines that are more sensitive to glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Unlinked regulation of the sensitivity of primary glucocorticoid-inducible responses in mouse mammary tumor virus infected Fu5-5 rat hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Repression of the alpha-fetoprotein gene promoter by progesterone and chimeric receptors in the presence of hormones and antihormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

The Factor Binding to the Glucocorticoid Modulatory Element of the Tyrosine Aminotransferase Gene Is a Novel and Ubiquitous Heteromeric Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

A negative tyrosine aminotransferase gene element that blocks glucocorticoid modulatory element-regulated modulation of glucocorticoid-induced gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Ability of the glucocorticoid modulatory element to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of glucocorticoid modulatory element and glucocorticoid response element activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Transactivation specificity of glucocorticoid versus progesterone receptors. Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Cloning and characterization of a novel binding factor (GMEB-2) of the glucocorticoid modulatory element

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Genomic organization of human GMEB-1 and rat GMEB-2: structural conservation of two multifunctional proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Suppressin: an endogenous negative regulator of immune cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Characterization of a nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related (NUDR) transcriptional regulator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Ubch9 conjugates SUMO but not ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

A functional interaction between dorsal and components of the Smt3 conjugation machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Molecular cloning, sequence analysis, expression, and tissue distribution of suppressin, a novel suppressor of cell cycle entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Regulation of transcriptional activation domain function by ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Role of CBP/P300 in nuclear receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200

The histone acetylase PCAF is a nuclear receptor coactivator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M112330200